Albuterol Sulfate Solution
Product Images NDC 64980-643
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 64980-643). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rising Pharma Holdings, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton Back Panel (Carton Back Panel)
This is a patient information guide for using Albuterol inhalation solution. It provides instructions on storing the medication, dosage details, and steps for using it with a nebulizer. The guide emphasizes the importance of following the directions provided by the physician and highlights safety precautions, such as discarding expired solutions and keeping the medication out of reach of children. It is recommended to read the instructions each time as they may be subject to changes.*
Carton-0.63mg (Carton 0.63mg)
Carton-1.25mg (Carton 1.25mg)
This is a description of Albuterol inhalation solution, with a concentration of 1.25 mg/3 mL. It comes in a package containing 25 individual sterile unit-dose vials, each placed in a foil pouch. The product is indicated for oral inhalation only and is commonly used to treat respiratory conditions such as asthma.*
Figure 1 (Figure 1)
This text appears to show a figure illustrating the % change from Pre-Dose FEV1 for an Intent-to-Treat Population on Day 1. It includes a comparison of albuterol and placebo treatments over different time intervals. The graph displays data points at various hours from Pre-Dose, ranging from 200 to 600, for both albuterol and placebo treatments.*
Figure 2 (Figure 2)
This is a comparative graph showing the percentage change from the pre-dose Forced Expiratory Volume in 1 second (FEV1) for an Intent-to-Treat population on Day 28. The graph depicts the response to treatment over time using albuterol at 1.25 mg, salbutamol at 0.63 mg, and placebo. The x-axis represents the hours from the pre-dose while the y-axis represents the percentage change.*
Figure 3 (Figure 3)
Figure 4 (Figure 4)
Figure 5 (Figure 5)
Figure 6 (Figure 6)
Pouch Label-0.63mg (Pouch Label 0.63mg)
This text provides detailed patient instructions for using Albuterol Inhalation Solution, including storage conditions, dosage information, and important safety precautions. It emphasizes following the directions closely and contacting healthcare professionals for any questions or concerns. The text includes step-by-step guidance on preparing and administering the medication using a nebulizer. It also lists the active and inactive ingredients in the solution and advises on proper storage and disposal of the vials. Overall, this information aims to ensure safe and effective use of the medication for oral inhalation.*
Pouch Label-1.25mg (Pouch Label 1.25mg)
This text provides detailed patient instructions for using Albuterol Inhalation Solution, a medication used for oral inhalation to treat conditions such as asthma and COPD. The instructions include steps for preparing the nebulizer, connecting it to a mouthpiece or face mask, using the nebulizer with the compressor, and breathing in the medication. It also includes important information about storage conditions, dosage, expiration date, and contact details for customer service. Overall, this text serves as a helpful guide for patients using Albuterol Inhalation Solution.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.